QUARTETTE (nda204061)- (0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A)

Generic Name	ETHINYL ESTRADIOL; LEVONORGESTREL	Innovator	TEVA BRANDED PHARM
Dosage	0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2029-Mar-11	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2016-Mar-28
GAIN Expiry	None	Drug Complexity	No
Indication	QUARTETTE® is indicated for use by females of reproductive age to prevent pregnancy.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
1	1	1

Other Developers

Total Other Developers	2

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A	**	**	-	-	1

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	1

Manufacturing Details of QUARTETTE